Livelsberger Financial Advisory Makes New $28,000 Investment in Agilent Technologies, Inc. (NYSE:A)

Livelsberger Financial Advisory acquired a new position in Agilent Technologies, Inc. (NYSE:A) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 185 shares of the medical research company’s stock, valued at approximately $28,000.

A number of other institutional investors and hedge funds have also modified their holdings of A. Vanguard Group Inc. increased its position in Agilent Technologies by 18.2% in the 1st quarter. Vanguard Group Inc. now owns 29,884,345 shares of the medical research company’s stock worth $4,348,471,000 after buying an additional 4,605,228 shares during the period. Massachusetts Financial Services Co. MA grew its stake in shares of Agilent Technologies by 5.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 15,064,660 shares of the medical research company’s stock worth $1,952,832,000 after acquiring an additional 809,149 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Agilent Technologies by 13.9% during the first quarter. Price T Rowe Associates Inc. MD now owns 8,542,054 shares of the medical research company’s stock worth $1,242,956,000 after acquiring an additional 1,042,926 shares during the period. Van ECK Associates Corp raised its stake in Agilent Technologies by 0.7% during the 2nd quarter. Van ECK Associates Corp now owns 2,793,189 shares of the medical research company’s stock valued at $362,081,000 after purchasing an additional 18,205 shares during the last quarter. Finally, Nordea Investment Management AB raised its stake in Agilent Technologies by 4.4% during the 1st quarter. Nordea Investment Management AB now owns 2,783,238 shares of the medical research company’s stock valued at $406,715,000 after purchasing an additional 116,822 shares during the last quarter. 87.42% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently issued reports on A. Stifel Nicolaus restated a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a report on Monday, August 26th. TD Cowen upped their price target on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Barclays lifted their price objective on Agilent Technologies from $135.00 to $145.00 and gave the stock an “underweight” rating in a report on Tuesday, October 15th. Wolfe Research cut Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research report on Thursday, June 27th. Finally, Bank of America upped their target price on Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $144.36.

Insider Transactions at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the sale, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $140.00, for a total value of $274,120.00. Following the transaction, the chief executive officer now owns 26,076 shares in the company, valued at $3,650,640. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,953 shares of company stock worth $2,013,630 in the last quarter. 0.33% of the stock is owned by company insiders.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock traded down $2.18 during trading on Monday, reaching $136.65. The company’s stock had a trading volume of 436,718 shares, compared to its average volume of 1,683,360. Agilent Technologies, Inc. has a one year low of $96.80 and a one year high of $155.35. The stock has a 50-day moving average price of $141.02 and a two-hundred day moving average price of $138.73. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $39.87 billion, a P/E ratio of 32.82, a price-to-earnings-growth ratio of 6.96 and a beta of 1.05.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the prior year, the firm earned $1.43 earnings per share. Agilent Technologies’s revenue was down 5.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be issued a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.69%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is 22.22%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.